Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For STAN.L
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 6.39 10.51 9.88
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1193.16 -215.87 16.69
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 8.13 16.32 15.09
Cash -5.11 20.04 21.12
Capex 0.00 0.00 0.00
Free Cash Flow 0.00 0.00 0.00
Revenue 35.39 1.66 1.23
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -3.44 0.97 1.00
Operating Margin 37.18 0.38 0.28
ROA 51.80 < 0.005 < 0.005
ROE 48.48 0.03 0.02
ROIC 79.10 0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of STAN.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of STAN.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of STAN.L is permitted for members.